Follow me on Twitter
I agree that content from Twitter will be displayed to me.
Head of Group
Director of Corporate Program
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Publications
Showing entries 326 - 330 out of 331
Chiba, P, Hitzler, M & Ecker, G 1997, 'Studies on propafenone-type modulators of multidrug resistance III: Variations on the nitrogen', QSAR & Combinatorial Science, vol. 16, no. 5, pp. 361-366. https://doi.org/10.1002/qsar.19970160502
Jäger, W, Ecker, G, Hitzler, M & Chiba, P 1997, 'Studies on propafenone-type modulators of multidrug resistance IV: synthesis and pharmacologic activity of 5-benzyloxy derivatives', Archiv der Pharmazie, vol. 330, pp. 343-347.
Prets, S, Jungreithmair, A, Chiba, P & Ecker, G 1996, 'Comparison of different methods for estimation of lipophilicity of propafenone-type modulators of multidrug resistance', Scientia Pharmaceutica, vol. 64, no. 3-4, pp. 627-636.
Chiba, P, Ecker, G, Schmid, D, Drach, J, Tell, B, Goldenberg, S & Gekeler, V 1996, 'Structural requirements for activity of propafenone-type modulators in P-glycoprotein-mediated multidrug resistance', Molecular Pharmacology, vol. 49, no. 6, pp. 1122-1130.
Ecker, G & Chiba, P 1995, 'Structure-activity-relationship studies on modulators of the multidrug transporter P-glycoprotein - An overview', Wiener Klinische Wochenschrift, vol. 107, no. 22, pp. 681-686.
Projects
Molecular Drug Targets
Hering, S. (Project Lead), Ecker, G. (Co-Lead), Maulide, N. (Co-Lead), Weinzinger, A. (Co-Lead) & Gonzalez Herrero, L. (Co-Lead)
1/12/10 → 31/12/22
Project: Research funding